GABA

Product Name:
Gamma-Aminobutyric Acid
Molecular Formula:

C₄H₉NO₂

Molecular Weight:
103.12
CAS No.:
56-12-2
Purity:
Specification 1: ≥95.0%
Specification 2: ≥99.0%

Description

Gamma-aminobutyric acid (GABA), also known as γ-aminobutyric acid, is the most important inhibitory neurotransmitter in the mammalian central nervous system.

Specifications

待定

Appearance White to slight yellow powder
Purity ≥95%
Assay (sodium-free and anhydrous basis) ≥90%
Sodium content 8%~11.5%
Water content ≤8%
pH (100mg/mL water) 9.5-11.5
Triethylamine ≤0.5%
Ethanol ≤1%

Function

  • Regulating neuronal excitability and maintaining the balance between excitation and inhibition in the brain;
  • Promoting relaxation and reducing stress and anxiety;
  • Supporting sleep and regulating sleep cycles;
  • Modulating muscle activity and motor coordination;
  • Suppressing abnormal neuronal activity and contributing to epilepsy regulation;
  • Participating in learning, memory, and neuroplasticity.

Application Direction

  • Dietary supplements and functional foods
  • Sleep support and stress management
  • Sports nutrition and recovery
  • Functional beverages
  • Pharmaceutical and neuroscience research

Product Advantages

待定

Why Choose Us

Release U Health Product Ltd is located in New York City, with a company investment exceeding tens of millions of US dollars. It boasts facilities spanning tens of thousands of square meters that comply with Good Manufacturing Practice (GMP) standards, supporting large-scale production of biosynthetic fermentation ingredients, medicinal extracts, as well as finished products such as soft candies, liquid bars, and tablets.

Its parent company has received support from major investors including Nestlé of Switzerland and Plug and Play. Through collaborations with various universities, the company has established a research and development platform encompassing cell engineering, pilot-scale testing, 30-ton fermentation, and full purification systems, backed by a robust portfolio of patents and intellectual property rights in publications.

Contact Us

Contact Us